#fda

Some US biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs watchdog under the ...

The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s LLY.N experimental treatment for early Alzheimer’s disease and will hold a meeting of ...

The U.S. Food and Drug Administration is close to making a decision on authorization of a second dose of updated COVID-19 vaccine boosters for high-risk people, the Wall Street ...

The U.S. Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd 4523.T and Biogen Inc BIIB.O for patients in the ...

The U.S. Food and Drug Administration authorized a third dose of COVID-19 vaccines from Pfizer Inc and Moderna Inc for people with compromised immune systems. The amended https://www....